Europe Blood and Blood Components Market to hit $5 billion by 2024: Global Market Insights, Inc.

Trauma & surgery segment of Europe blood and blood components market accounted for more than 40% revenue share in 2017 and is projected to achieve significant CAGR up to 2024 owing to growing number of injuries as well as surgical procedure.


Selbyville, Delaware, June 19, 2019 (GLOBE NEWSWIRE) --

Russia blood and blood components market is estimated to witness fastest growth to reach USD 840 million by 2024. Growing geriatric population base prone to suffer from various chronic diseases and high number of surgical procedures should upsurge the demand for blood transfusion. Moreover, rising number of initiatives to motivate the population to donate blood will propel Russia blood and blood components market growth.

Trauma and surgery application segment accounted for over 40% market share in 2017. Increasing number of injuries and surgical procedures will stimulate demand for blood and blood components over the coming years. Massive blood transfusion necessary in majority of trauma cases will drive segmental growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3398

Based on end-use, the industry is bifurcated into hospitals, ambulatory surgical centers and others. Ambulatory surgical centers is anticipated to reach USD 1.5 billion by 2024 owing to improved outcomes delivered at outpatient surgical facilities at less cost as compared to hospitals.

The Europe Blood and Blood Components Market value is poised to surpass USD 5 billion by 2024; according to a new research study published by Global Market Insights, Inc. Increasing risk of infection resulting from transfusion of blood and blood components along with decreasing number of blood donations will decrease Europe blood and blood components market size during the forecast years. As per forecasts, transfusion of red blood cells will decrease from 15.7 million units in 2013 to 13.9 million units by 2024.

Increasing number of surgeries and other treatments such as chemotherapy requiring external supply to blood and blood components will sustain the market demand over the forecast timeframe. Furthermore, growing number of cosmetic procedures utilizing blood components will positively impact blood components market. However, programmes such as ‘optimal use of blood’ to reduce wastage of blood and blood components along with declining number of blood donations will diminish the market size to certain extent over the coming years.

Browse key industry insights spread across 103 pages with 122 market data tables & 8 figures & charts from the report, “Europe Blood and Blood Components Market Size By Product (Whole Blood, Blood Components {Red Blood Cells, Platelets, Plasma, White Blood Cells}), By Application (Anemia, Trauma & Surgery, Cancer Treatment, Bleeding Disorders), By End-Use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Country Outlook (Germany, UK, France, Spain, Italy, Russia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024” in detail along with the table of contents:   

https://www.gminsights.com/industry-analysis/europe-blood-and-blood-components-market

Blood components segment dominated the industry in 2017 and is estimated to reach USD 3.9 billion by 2024. According to the estimates, transfusion of blood components will reduce from 21.9 million units in 2013 to 18.9 million units by 2024. Rising awareness about efficient use of blood and blood components, growing application of blood components in aesthetic procedures and treatments such as chemotherapy will sustain the demand for blood components market over the forecast period.

Major players operating in Europe blood and blood components market include International Federation of Red Cross and Red Crescent Societies (IFRC), American Association of Blood Banks (AABB), Welsh Blood Services, NHS Blood and Transplant (NHSBT) and the Northern Ireland Blood Transfusion Service.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3398

Browse Related Reports:

Blood and Blood Components Market By Application (Anemia, Trauma & Surgery, Cancer Treatment, Bleeding Disorders), By Product (Whole Blood, Blood Components {Red Blood Cells, Platelets, Plasma, White Blood Cells}), By End-Use (Hospitals, Ambulatory Surgical Centers) Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, France, Spain, Italy, Russia, China, India, Japan, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024

https://www.gminsights.com/industry-analysis/blood-and-blood-components-market

Platelet and Plasma Market By Application (Hemophilia, Thrombocytopenia, Perioperative Indications, Platelet Function Disorders, Coagulation Factor Deficiencies, Thrombotic Thrombocytopenic Purpura, Hemorrhage, Liver Disease), By Component (Platelets, Plasma), By Distribution Channel (Hospitals, Ambulatory Surgical Centers) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, India, China, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Competitive Market Share & Forecast, 2018 - 2024

https://www.gminsights.com/industry-analysis/platelet-and-plasma-market

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.


            

Contact Data